BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

502 related articles for article (PubMed ID: 24021863)

  • 1. Stress and visceral pain: focusing on irritable bowel syndrome.
    Fukudo S
    Pain; 2013 Dec; 154 Suppl 1():S63-S70. PubMed ID: 24021863
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Visceral hypersensitivity in irritable bowel syndrome.
    Kanazawa M; Hongo M; Fukudo S
    J Gastroenterol Hepatol; 2011 Apr; 26 Suppl 3():119-21. PubMed ID: 21443723
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of corticotropin-releasing hormone in irritable bowel syndrome and intestinal inflammation.
    Fukudo S
    J Gastroenterol; 2007 Jan; 42 Suppl 17():48-51. PubMed ID: 17238026
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential Activation in Amygdala and Plasma Noradrenaline during Colorectal Distention by Administration of Corticotropin-Releasing Hormone between Healthy Individuals and Patients with Irritable Bowel Syndrome.
    Tanaka Y; Kanazawa M; Kano M; Morishita J; Hamaguchi T; Van Oudenhove L; Ly HG; Dupont P; Tack J; Yamaguchi T; Yanai K; Tashiro M; Fukudo S
    PLoS One; 2016; 11(7):e0157347. PubMed ID: 27448273
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cognitive behavioral therapy for irritable bowel syndrome: the effects on state and trait anxiety and the autonomic nervous system during induced rectal distensions - An uncontrolled trial.
    Edebol-Carlman H; Schrooten M; Ljótsson B; Boersma K; Linton S; Brummer RJ
    Scand J Pain; 2018 Jan; 18(1):81-91. PubMed ID: 29794287
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Altered brain and gut responses to corticotropin-releasing hormone (CRH) in patients with irritable bowel syndrome.
    Kano M; Muratsubaki T; Van Oudenhove L; Morishita J; Yoshizawa M; Kohno K; Yagihashi M; Tanaka Y; Mugikura S; Dupont P; Ly HG; Takase K; Kanazawa M; Fukudo S
    Sci Rep; 2017 Sep; 7(1):12425. PubMed ID: 28963545
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impaired emotional learning and involvement of the corticotropin-releasing factor signaling system in patients with irritable bowel syndrome.
    Labus JS; Hubbard CS; Bueller J; Ebrat B; Tillisch K; Chen M; Stains J; Dukes GE; Kelleher DL; Naliboff BD; Fanselow M; Mayer EA
    Gastroenterology; 2013 Dec; 145(6):1253-61.e1-3. PubMed ID: 23954313
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gene, environment, and brain-gut interactions in irritable bowel syndrome.
    Fukudo S; Kanazawa M
    J Gastroenterol Hepatol; 2011 Apr; 26 Suppl 3():110-5. PubMed ID: 21443722
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The gastrointestinal motor function in irritable bowel syndrome (IBS)].
    Sagami Y; Hongo M
    Nihon Rinsho; 2006 Aug; 64(8):1441-5. PubMed ID: 16898609
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Abdominal pain in Irritable Bowel Syndrome: a review of putative psychological, neural and neuro-immune mechanisms.
    Elsenbruch S
    Brain Behav Immun; 2011 Mar; 25(3):386-94. PubMed ID: 21094682
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Imipramine improves visceral sensation and gut barrier in rat models of irritable bowel syndrome.
    Nozu T; Miyagishi S; Ishioh M; Takakusaki K; Okumura T
    Eur J Pharmacol; 2020 Nov; 887():173565. PubMed ID: 32946869
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of Microglial Activation in the Amygdala Reverses Stress-Induced Abdominal Pain in the Male Rat.
    Yuan T; Manohar K; Latorre R; Orock A; Greenwood-Van Meerveld B
    Cell Mol Gastroenterol Hepatol; 2020; 10(3):527-543. PubMed ID: 32408032
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The brain-gut axis in irritable bowel syndrome--clinical aspects.
    Mach T
    Med Sci Monit; 2004 Jun; 10(6):RA125-31. PubMed ID: 15173682
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of a corticotropin releasing hormone receptor antagonist on colonic sensory and motor function in patients with irritable bowel syndrome.
    Sagami Y; Shimada Y; Tayama J; Nomura T; Satake M; Endo Y; Shoji T; Karahashi K; Hongo M; Fukudo S
    Gut; 2004 Jul; 53(7):958-64. PubMed ID: 15194643
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanisms of Stress-Induced Visceral Pain: Implications in Irritable Bowel Syndrome.
    Greenwood-Van Meerveld B; Moloney RD; Johnson AC; Vicario M
    J Neuroendocrinol; 2016 Aug; 28(8):. PubMed ID: 26749172
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gender-related differences in irritable bowel syndrome: potential mechanisms of sex hormones.
    Meleine M; Matricon J
    World J Gastroenterol; 2014 Jun; 20(22):6725-43. PubMed ID: 24944465
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serotonin receptors and their role in the pathophysiology and therapy of irritable bowel syndrome.
    Stasi C; Bellini M; Bassotti G; Blandizzi C; Milani S
    Tech Coloproctol; 2014 Jul; 18(7):613-21. PubMed ID: 24425100
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stress and the Microbiota-Gut-Brain Axis in Visceral Pain: Relevance to Irritable Bowel Syndrome.
    Moloney RD; Johnson AC; O'Mahony SM; Dinan TG; Greenwood-Van Meerveld B; Cryan JF
    CNS Neurosci Ther; 2016 Feb; 22(2):102-17. PubMed ID: 26662472
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Irritable Bowel Syndrome: A Clinical Review.
    Cashman MD; Martin DK; Dhillon S; Puli SR
    Curr Rheumatol Rev; 2016; 12(1):13-26. PubMed ID: 26717952
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuroimmune Cross Talk in the Gut. Neuroendocrine and neuroimmune pathways contribute to the pathophysiology of irritable bowel syndrome.
    O'Malley D
    Am J Physiol Gastrointest Liver Physiol; 2016 Nov; 311(5):G934-G941. PubMed ID: 27742703
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.